↓ Skip to main content

The impact of Emblica Officinalis (Amla) on lipid profile, glucose, and C-reactive protein: A systematic review and meta-analysis of randomized controlled trials

Overview of attention for article published in Diabetes & Metabolic Syndrome: Clinical Research & Reviews, March 2023